:: Re: [DNG] system administration of …
Top Page
Delete this message
Reply to this message
Author: dng@d404.nl
Date:  
To: dng
Subject: Re: [DNG] system administration of non-systemd distros and releases
On 26-11-2021 21:53, Dr. Nikolaus Klepp via Dng wrote:
> Anno domini 2021 Fri, 26 Nov 15:33:11 -0500
> Ken Dibble scripsit:
>> On 11/26/21 1:57 PM, dng@??? wrote:
>>> On 26-11-2021 17:27, golinux@??? wrote:
>>>> On 2021-11-26 05:08, Peter Duffy wrote:
>>>>> It's a bit like the charlatans and fake doctors in past centuries.
>>>>> They'd invent an illness, and then claim to have a remedy for it:
>>>>>
>>>>> https://en.wiktionary.org/wiki/marthambles
>>>>>
>>>>>
>>>> LOL! Isn't that exactly what big pharma is still doing with direct
>>>> marketing to consumers of their latest "cure" for a newly discovered
>>>> "disease"?
>>>>
>>>> golinux
>>>> _______________________________________________
>>>> Dng mailing list
>>>> Dng@???
>>>> https://mailinglists.dyne.org/cgi-bin/mailman/listinfo/dng
>>> Well, big pharma does do some research and sometimes come with new and
>>> useful medication. But it is true that they spend more on marketing
>>> than on research.
>>>
>>> Grtz
>>>
>>> Nick
>>>
>>> _______________________________________________
>>> Dng mailing list
>>> Dng@???
>>> https://mailinglists.dyne.org/cgi-bin/mailman/listinfo/dng
>> I am not trying to create problems of any type.  I would honestly like
>> the source of the claim that big pharma spends more on marketing than on
>> research, before I repeat it, and am left without a defense.
> 5% R&D, 45% Marketing, 50% profit - at least these were the last published numbers. Sorry, I just have a source in german:
> https://www.amazon.de/Lizenz-Pl%C3%BCndern-multilaterale-Abkommen-Investitionen/dp/3434530177
>
> This book ist not the newest, but it has valid numbers. And both authors have quite a name :)
>
> Nik
>
>>
>> Ken
>>
>> _______________________________________________
>> Dng mailing list
>> Dng@???
>> https://mailinglists.dyne.org/cgi-bin/mailman/listinfo/dng
>>

This is reasonable recent
https://www.pharmacychecker.com/askpc/pharma-marketing-research-development/

Grtz

Nick